549 related articles for article (PubMed ID: 12377342)
1. In vitro enhancement of tumor cell radiosensitivity by a selective inhibitor of cyclooxygenase-2 enzyme: mechanistic considerations.
Raju U; Nakata E; Yang P; Newman RA; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):886-94. PubMed ID: 12377342
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of intrinsic tumor cell radiosensitivity induced by a selective cyclooxygenase-2 inhibitor.
Petersen C; Petersen S; Milas L; Lang FF; Tofilon PJ
Clin Cancer Res; 2000 Jun; 6(6):2513-20. PubMed ID: 10873107
[TBL] [Abstract][Full Text] [Related]
3. Preferential enhancement of tumor radioresponse by a cyclooxygenase-2 inhibitor.
Kishi K; Petersen S; Petersen C; Hunter N; Mason K; Masferrer JL; Tofilon PJ; Milas L
Cancer Res; 2000 Mar; 60(5):1326-31. PubMed ID: 10728694
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase (COX)-2-dependent effects of the inhibitor SC236 when combined with ionizing radiation in mammary tumor cells derived from HER-2/neu mice.
Lanza-Jacoby S; Dicker AP; Miller S; Rosato FE; Flynn JT; Lavorgna SN; Burd R
Mol Cancer Ther; 2004 Apr; 3(4):417-24. PubMed ID: 15078985
[TBL] [Abstract][Full Text] [Related]
5. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
[TBL] [Abstract][Full Text] [Related]
6. Radiosensitivity enhancement by celecoxib, a cyclooxygenase (COX)-2 selective inhibitor, via COX-2-dependent cell cycle regulation on human cancer cells expressing differential COX-2 levels.
Shin YK; Park JS; Kim HS; Jun HJ; Kim GE; Suh CO; Yun YS; Pyo H
Cancer Res; 2005 Oct; 65(20):9501-9. PubMed ID: 16230415
[TBL] [Abstract][Full Text] [Related]
7. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
8. Combination of radiation and celebrex (celecoxib) reduce mammary and lung tumor growth.
Liu W; Chen Y; Wang W; Keng P; Finkelstein J; Hu D; Liang L; Guo M; Fenton B; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S103-9. PubMed ID: 12902866
[TBL] [Abstract][Full Text] [Related]
9. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
10. Pronounced radiosensitization of cultured human cancer cells by COX inhibitor under acidic microenvironment.
Shah T; Ryu S; Lee HJ; Brown S; Kim JH
Int J Radiat Oncol Biol Phys; 2002 Aug; 53(5):1314-8. PubMed ID: 12128134
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 inhibitor NS398 enhances antitumor effect of irradiation on hormone refractory human prostate carcinoma cells.
Wen B; Deutsch E; Eschwege P; De Crevoisier R; Nasr E; Eschwege F; Bourhis J
J Urol; 2003 Nov; 170(5):2036-9. PubMed ID: 14532848
[TBL] [Abstract][Full Text] [Related]
12. NS 398 radiosensitizes an HNSCC cell line by possibly inhibiting radiation-induced expression of COX-2.
Amirghahari N; Harrison L; Smith M; Rong X; Naumann I; Ampil F; Shi R; Glass J; Nathan CO
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1405-12. PubMed ID: 14630280
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-kappaB activation and phosphorylation of p38 mitogen-activated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells.
Kim SJ; Jeong HJ; Choi IY; Lee KM; Park RK; Hong SH; Kim HM
J Pharmacol Exp Ther; 2005 Jul; 314(1):27-34. PubMed ID: 15784648
[TBL] [Abstract][Full Text] [Related]
14. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
[TBL] [Abstract][Full Text] [Related]
15. Celecoxib induced tumor cell radiosensitization by inhibiting radiation induced nuclear EGFR transport and DNA-repair: a COX-2 independent mechanism.
Dittmann KH; Mayer C; Ohneseit PA; Raju U; Andratschke NH; Milas L; Rodemann HP
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):203-12. PubMed ID: 17996386
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent modulation of apoptosis and cyclooxygenase-2 expression in human 1547 osteosarcoma cells by NS-398, a selective cyclooxygenase-2 inhibitor.
Moalic S; Liagre B; Le Bail JC; Beneytout JL
Int J Oncol; 2001 Mar; 18(3):533-40. PubMed ID: 11179483
[TBL] [Abstract][Full Text] [Related]
18. Celecoxib inhibits proliferation and induces apoptosis via prostaglandin E2 pathway in human cholangiocarcinoma cell lines.
Wu GS; Zou SQ; Liu ZR; Tang ZH; Wang JH
World J Gastroenterol; 2003 Jun; 9(6):1302-6. PubMed ID: 12800245
[TBL] [Abstract][Full Text] [Related]
19. Prediction of poor survival by cyclooxygenase-2 in patients with T4 nasopharyngeal cancer treated by radiation therapy: clinical and in vitro studies.
Chen WC; McBride WH; Chen SM; Lee KF; Hwang TZ; Jung SM; Shau H; Liao SK; Hong JH; Chen MF
Head Neck; 2005 Jun; 27(6):503-12. PubMed ID: 15772955
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib enhances radiosensitivity via induction of G₂-M phase arrest and apoptosis in nasopharyngeal carcinoma.
Zhang SX; Qiu QH; Chen WB; Liang CH; Huang B
Cell Physiol Biochem; 2014; 33(5):1484-97. PubMed ID: 24854838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
